Common Use
Tambocor (flecainide acetate) is a Class IC antiarrhythmic medication used to treat serious cardiac arrhythmias, including life-threatening ventricular arrhythmias and supraventricular tachycardia, as well as atrial fibrillation and atrial flutter. Flecainide works by slowing down the electrical conduction in the heart, helping to restore and maintain a normal, stable heart rhythm. This medication is typically prescribed for patients with symptomatic or life-threatening irregular heartbeats that have not responded adequately to other treatments. Tambocor is also commonly used for the prevention of paroxysmal atrial fibrillation (PAF) and paroxysmal supraventricular tachycardia (PSVT) in patients without structural heart disease. If you are looking to buy Tambocor online, this proven antiarrhythmic agent provides reliable heart rhythm control when used as directed.

Dosage and Direction
Dosage of Tambocor is highly individualized based on the patient's specific arrhythmia type, cardiac function, and treatment response. Adults typically start with a lower dose of 50-100 mg taken orally twice daily. Your doctor may gradually increase the dose at intervals of at least four days until optimal rhythm control is achieved, with a maximum recommended dose of 300-400 mg per day depending on the condition. Take the medication at evenly spaced intervals, with or without food. Do not change the dose or stop taking Tambocor without consulting your doctor, as abrupt discontinuation may worsen arrhythmias. Flecainide blood levels may be monitored periodically to ensure therapeutic concentrations.

Precautions
Before starting Tambocor, inform your doctor if you have heart failure, structural heart disease, cardiomyopathy, conduction abnormalities, liver or kidney problems, or electrolyte imbalances (especially low potassium or magnesium). Regular heart monitoring through electrocardiogram (ECG) is essential during treatment, as flecainide can paradoxically worsen arrhythmias (proarrhythmic effect) in some patients. Your doctor should correct any electrolyte imbalances before initiating therapy. Avoid alcohol and medications known to affect heart rhythm unless specifically approved by your healthcare provider. Patients with pacemakers should have their devices checked regularly during Tambocor therapy.

Contraindications
Tambocor must not be used if you have cardiogenic shock, second- or third-degree AV block (without a pacemaker), right bundle branch block when associated with a left hemiblock (bifascicular block), or structural heart disease. It is contraindicated in severe heart failure and in patients with known hypersensitivity to flecainide acetate or any of its components. Tambocor should not be initiated during an acute myocardial infarction (heart attack). The CAST trial demonstrated increased mortality with Class IC antiarrhythmics in post-MI patients with asymptomatic ventricular arrhythmias. Patients with Brugada syndrome should avoid this medication.

Possible Side Effects
Common side effects of Tambocor include dizziness, blurred vision, visual disturbances, headache, nausea, fatigue, and tremor. More serious adverse reactions may include new or worsened arrhythmias (proarrhythmic effect), chest pain, shortness of breath, palpitations, or fainting (syncope). Heart failure may develop or worsen in susceptible patients. Liver function abnormalities have been reported rarely. Contact your healthcare provider immediately if you experience any unusual symptoms, especially irregular or rapid heartbeat, chest discomfort, or difficulty breathing.

Drug Interaction
Tambocor can interact with other antiarrhythmic drugs (such as amiodarone, propafenone, or digoxin), beta-blockers, calcium channel blockers, certain antidepressants (SSRIs, tricyclics), and medications affecting heart rhythm or cardiac conduction. These interactions may significantly increase the risk of serious arrhythmias, bradycardia, or heart failure. CYP2D6 inhibitors such as fluoxetine and paroxetine may increase flecainide levels. Ritonavir may also significantly increase flecainide concentrations. Urinary alkalinizers or acidifiers can affect flecainide elimination. Always inform your doctor about all medications, supplements, and herbal products you are taking.

Missed Dose
If a dose of Tambocor is missed, take it as soon as possible. If it is near the time of your next dose, skip the missed dose and resume your regular schedule. Never take a double dose to make up for a missed one, as this can cause dangerous cardiac effects. Consistent dosing is crucial for maintaining heart rhythm control.

Overdose
Overdose of Tambocor may cause severe and potentially fatal heart rhythm disturbances, cardiac arrest, heart failure, fainting, respiratory failure, or seizures. Seek immediate emergency medical attention if an overdose is suspected. Emergency treatment may include activated charcoal, sodium bicarbonate or hypertonic sodium lactate infusion to counteract cardiac conduction abnormalities, temporary pacing, mechanical ventilation, and other supportive measures to stabilize the heart.

Storage
Store Tambocor at room temperature between 15-30 degrees C (59-86 degrees F), away from heat, moisture, and direct sunlight. Keep the medication in its original container. Keep out of reach of children and pets. Do not use Tambocor past its expiration date.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.